| COVID-19 surface persistence: a recent data summary and its importance for medical and dental settings L Fiorillo, G Cervino, M Matarese, C D’Amico, G Surace, V Paduano, ... International journal of environmental research and public health 17 (9), 3132, 2020 | 218 | 2020 |
| State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation M Casali, C Lauri, C Altini, F Bertagna, G Cassarino, A Cistaro, AP Erba, ... Clinical and Translational Imaging 9 (4), 299-339, 2021 | 93 | 2021 |
| Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience G Giuffrida, F Ferrau, R Laudicella, OR Cotta, E Messina, F Granata, ... Endocrine connections 8 (5), 528-535, 2019 | 61 | 2019 |
| Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: An explorative study on machine learning feature classification in … P Alongi, A Stefano, A Comelli, R Laudicella, S Scalisi, G Arnone, ... European Radiology 31, 4595-4605, 2021 | 60 | 2021 |
| What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression … JH Rüschoff, DA Ferraro, UJ Muehlematter, R Laudicella, T Hermanns, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 4042-4053, 2021 | 57 | 2021 |
| Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients A Campennì, L Giovanella, SA Pignata, A Vento, A Alibrandi, L Sturiale, ... Oncotarget 9 (25), 17491, 2018 | 47 | 2018 |
| [68Ga] Ga-PSMA versus [18F] PSMA positron emission tomography/computed tomography in the staging of primary and recurrent prostate cancer. a systematic review of the literature L Evangelista, T Maurer, H van der Poel, F Alongi, J Kunikowska, ... European Urology Oncology 5 (3), 273-282, 2022 | 46 | 2022 |
| SARS-CoV-2 persistence: data summary up to Q2 2020 G Cervino, L Fiorillo, G Surace, V Paduano, MT Fiorillo, R De Stefano, ... Data 5 (3), 81, 2020 | 46 | 2020 |
| Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy A Campennì, M Siracusa, RM Ruggeri, R Laudicella, SA Pignata, ... Scientific reports 7 (1), 6147, 2017 | 43 | 2017 |
| 18F-Facbc in Prostate Cancer: A Systematic Review and Meta-Analysis R Laudicella, D Albano, P Alongi, G Argiroffi, M Bauckneht, S Baldari, ... Cancers 11 (9), 1348, 2019 | 39 | 2019 |
| Somatostatin receptor PET/CT imaging for the detection and staging of pancreatic NET: a systematic review and meta-analysis M Bauckneht, D Albano, S Annunziata, G Santo, P Guglielmo, ... Diagnostics 10 (8), 598, 2020 | 38 | 2020 |
| Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey S Annunziata, M Bauckneht, D Albano, G Argiroffi, D Calabrò, ... European journal of nuclear medicine and molecular imaging 47, 2090-2099, 2020 | 38 | 2020 |
| Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics V Liberini, R Laudicella, M Balma, DG Nicolotti, A Buschiazzo, S Grimaldi, ... European radiology experimental 6 (1), 27, 2022 | 37 | 2022 |
| Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements L Baratto, H Duan, R Laudicella, A Toriihara, N Hatami, V Ferri, A Iagaru European Journal of Nuclear Medicine and Molecular Imaging 47, 115-122, 2020 | 35 | 2020 |
| The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients M Bauckneht, F Bertagna, MI Donegani, R Durmo, A Miceli, V De Biasi, ... Prostate Cancer and Prostatic Diseases 24 (4), 1198-1207, 2021 | 28 | 2021 |
| The future of cancer diagnosis, treatment and surveillance: A systemic review on immunotherapy and immuno-pet radiotracers V Liberini, R Laudicella, M Capozza, MW Huellner, IA Burger, S Baldari, ... Molecules 26 (8), 2201, 2021 | 27 | 2021 |
| The role of 18F-FDG PET/CT in staging and prognostication of mantle cell lymphoma: an Italian multicentric study D Albano, R Laudicella, P Ferro, M Allocca, E Abenavoli, A Buschiazzo, ... Cancers 11 (12), 1831, 2019 | 26 | 2019 |
| [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept R Laudicella, A Comelli, V Liberini, A Vento, A Stefano, A Spataro, ... Cancers 14 (4), 984, 2022 | 25 | 2022 |
| Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study. P Alongi, R Laudicella, A Stefano, F Caobelli, A Comelli, A Vento, ... The quarterly journal of nuclear medicine and molecular imaging: official …, 2020 | 24 | 2020 |
| PSMA and choline PET for the assessment of response to therapy and survival outcomes in prostate cancer patients: a systematic review from the literature P Alongi, R Laudicella, H Lanzafame, A Farolfi, P Mapelli, M Picchio, ... Cancers 14 (7), 1770, 2022 | 23 | 2022 |
